Brands: Emend · Aprepitant
Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc., USA | generic | 6 | SUPPLYING |
| Sandoz Inc | generic | 5 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 5 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 5 | SUPPLYING |
| BluePoint Laboratories | relabeler | 5 | SUPPLYING |
| MERCK SHARP & DOHME LLC | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Aprepitant Oral Powder for Suspension — reported in shortage by Merck Sharp & Dohme LLC. Therapeutic category: Gastroenterology.
Aprepitant Oral Powder for Suspension — reported in shortage by Merck Sharp & Dohme LLC. Therapeutic category: Gastroenterology.
Presence of particulate matter: potential presence of metal particulates in the product. — Recalling firm: Merck Sharp & Dohme LLC — Nationwide in the USA
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide
